PROCEEDINGS OF 32ND ANNUAL GENERAL MEETING OF THE COMPANY
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Limited held its 32nd AGM on Tuesday, 30th September 2025 at 11:00 AM in Indore, with 45 members attending out of 7,501 total members. All four resolutions on the agenda were passed: (1) approval of the audited standalone financial statements for FY ending 31st March 2025, (2) re-appointment of Mr. Sudhir Sethi (DIN: 00090172) as Director retiring by rotation, (3) appointment of Dipika Kataria & Co as Secretarial Auditors for a five-year term until the 37th AGM in 2030, and (4) re-appointment of Mr. Sanjay Sethi (DIN: 00090277) as Managing Director for a further five years (passed as a special resolution). Voting was conducted through remote e-voting and poll, with CS Dipika Kataria appointed as scrutinizer. The meeting concluded at 2:15 PM.
Routine procedural outcomes with no change to capital structure or business operations. Leadership continuity maintained with the promoter-family MD reappointed for another 5-year term. Likely neutral impact on the stock; small-cap pharma company with thin float.